How Does The Radiofrequency Atrial Septal Puncture Needle Usher In A New Era Of Structural Heart Disease Treatment?
May 29, 2026
Transseptal puncture (TSP) used to be a high-risk procedure that required extensive experience and precise skills from cardiologists. The widespread use of radiofrequency septal puncture needles has made this crucial step safer, more standardized, and more teachable, thereby significantly promoting the rapid development of left atrial interventional therapy. It has evolved from a simple atrial fibrillation ablation tool to a "universal key" that opens the door to left heart interventional treatment.
Core Application Scenarios: From Electrophysiology to Structural Heart Diseases
- Catheter ablation for atrial fibrillation: This is the earliest and most important application of radiofrequency atrial septal puncture needles. By establishing a left atrial pathway, it is the first step in performing ablation procedures such as pulmonary vein isolation. Its high success rate and safety enable more centers to carry out complex atrial fibrillation ablation surgeries.
- Left atrial appendage closure (LAAC): To prevent stroke in patients with atrial fibrillation. The closure device needs to be inserted into the left atrial appendage through the atrial septum. Safe and precise puncture is the prerequisite for the success of the surgery. Radiofrequency puncture needles have obvious advantages in handling thickened or abnormally shaped atrial septa.
- Interventional treatment of mitral valve: Such as percutaneous mitral balloon valvuloplasty or edge-to-edge repair (such as MitraClip), a stable left atrial pathway is required. Radiofrequency puncture needles provide a reliable entry guarantee for these difficult valve intervention surgeries.
- Left ventricular assist device (LVAD) implantation monitoring and hemodynamic assessment: In some cases where precise monitoring of left heart pressure is required in the management of heart failure patients, a left heart pathway needs to be established.
- Pediatric cardiology: For children with congenital heart disease, their hearts are smaller and more fragile. The precise and controllable characteristics of radiofrequency puncture needles provide higher safety.
The Core Advantages Driving the Development of the Industry
- Lower the technical threshold and expand surgical accessibility: Traditional mechanical puncture highly relies on the surgeon's experience. The "press-button and puncture" mode of radiofrequency puncture has reduced the learning curve, enabling more hospitals and younger doctors to safely perform left heart interventional surgeries, and allowing advanced technology to benefit a wider range of patients.
- Address complex cases and expand treatment boundaries: With an aging population, there are more patients with thickened, fibrotic atria and those who have undergone multiple previous surgeries. Radiofrequency puncture needles are effective tools for dealing with these "difficult atria," providing treatment opportunities for cases that were previously considered prohibitive or high-risk.
- Shorten the operation time and optimize medical resources: Faster puncture means shorter overall operation time and less X-ray exposure, improving the efficiency of the catheterization room and reducing medical costs.
- Collaborate with imaging fusion technology: Radiofrequency puncture needles are often used in combination with intracardiac ultrasound (ICE) and three-dimensional electroanatomical mapping systems. The non-irradiating markers at the tip of the needle facilitate clear positioning on the image, enabling true "visualized" puncture and raising the surgical accuracy to a new level.
The Role of Manners Technology: Empowering Global Innovation
As a manufacturing partner for international leading brands such as Baylis Medical (Boston Scientific), Manners Technology plays a crucial role. It is not merely a contract manufacturer but also a provider of precision manufacturing solutions. Its core capabilities lie in:
Large-scale precision manufacturing: Utilizing equipment such as Citizen R04, we can achieve large-scale, stable production with micrometer-level precision, meeting the continuously growing demand for high-quality RF puncture needles in the global market.
Collaborative technology and rapid response: We can closely collaborate with the R&D teams of the brand to quickly conduct design iterations and sample trials based on new clinical requirements (such as finer diameters, different head-end designs, and compatibility with new sheaths).
Quality and compliance guarantee: Its well-established ISO 13485 system ensures that the products comply with regulatory requirements in major global markets (such as the US FDA, EU CE, etc.), providing a solid foundation for brands to launch their innovative products to the world.
Future Outlook
With the continuous innovation in the field of interventional treatment for structural heart diseases (such as the vigorous development of interventional techniques for mitral and tricuspid valves), the demand for safe and reliable atrial septal access only increases. The radiofrequency atrial septal puncture needle technology itself is also evolving, for example, better integration with adjustable flexible sheaths, and further intelligence in energy release patterns. Companies like Manners Technology, which focus on the precise manufacturing of advanced medical devices, will continue to provide clinicians with more superior tools through their outstanding engineering and manufacturing capabilities, jointly driving minimally invasive cardiovascular interventional treatment towards a safer and more precise future.








